Book

Description

This book provides a comprehensive overview of radiotherapy fractionation strategies in prostate cancer, with a particular focus on the comparison between conventional fractionation and hypofractionated radiotherapy. It reviews the radiobiological rationale, treatment planning principles, clinical outcomes, toxicity profiles, and quality-of-life considerations associated with different fractionation schedules. Evidence from major randomized clinical trials and contemporary guidelines is discussed to help clinicians understand the benefits and limitations of each approach. The book also highlights advances in intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and emerging treatment techniques that continue to improve the therapeutic ratio for patients with localized and locally advanced prostate cancer.